Concerns about genetic risk testing for opioid use disorder.
Hatoum AS, Davis CN, Kember RL, Johnstone M, Oslin DW, Zinkstok JR, Burmeister M; Ethics, Position, and Public Policy Committee of the International Society of Psychiatric Genetics, Board of Directors of the International Society of Psychiatric Genetics; Agrawal A, Kranzler HR, Edenberg HJ, Gelernter J, Docherty AR, Lencz T.
Hatoum AS, et al. Among authors: gelernter j.
Lancet Psychiatry. 2024 Oct 11:S2215-0366(24)00310-9. doi: 10.1016/S2215-0366(24)00310-9. Online ahead of print.
Lancet Psychiatry. 2024.
PMID: 39413801
No abstract available.